Technical Analysis for NMRA - Neumora Therapeutics, Inc.

Grade Last Price % Change Price Change
A 13.22 11.84% 1.40
NMRA closed up 11.84 percent on Thursday, September 28, 2023, on 51 percent of normal volume.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Up

Date Alert Name Type % Chg
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
Up 5 Days in a Row Strength 0.00%
Shooting Star Candlestick Bearish 11.84%
Doji - Bearish? Reversal 11.84%
Up 3 Days in a Row Strength 11.84%
Up 4 Days in a Row Strength 11.84%
Up 5 Days in a Row Strength 11.84%
NR7 Range Contraction 12.89%
Inside Day Range Contraction 12.89%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Rose Above Previous Day's High about 12 hours ago
Up 10% about 13 hours ago
Gap Down Partially Closed about 14 hours ago
Gap Down Closed about 14 hours ago
Reversed from Down about 14 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Neumora Therapeutics, Inc. Description

Neumora Therapeutics, Inc. is a clinical-stage biopharmaceutical company founded to confront the global brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. Neumora’s therapeutic pipeline currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Neumora’s work is supported by an integrated suite of translational, clinical, and computational tools to generate insights that can enable precision medicine approaches. Neumora’s mission is to redefine neuroscience drug development by bringing forward the next generation of novel therapies that offer improved treatment outcomes and quality of life for patients suffering from brain diseases. Neumora has operations in the Greater Boston Area and South San Francisco.


Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Neuroscience Drug Development Neurodegenerative Diseases

Is NMRA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 17.7394
52 Week Low 9.9
Average Volume 713,334
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 0.00
10-Day Moving Average 12.34
Average True Range 0.00
RSI (14) 0.00
ADX 0.0
+DI 0.00
-DI 0.00
Chandelier Exit (Long, 3 ATRs) N/A
Chandelier Exit (Short, 3 ATRs) N/A
Upper Bollinger Bands 0.00
Lower Bollinger Band 0.00
Percent B (%b) 0.0
BandWidth 0.00
MACD Line 0.00
MACD Signal Line 0.00
MACD Histogram 0.0
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 16.85
Resistance 3 (R3) 16.79 15.51 16.25
Resistance 2 (R2) 15.51 14.59 15.55 16.04
Resistance 1 (R1) 14.37 14.02 14.94 14.43 15.84
Pivot Point 13.09 13.09 13.38 13.13 13.09
Support 1 (S1) 11.95 12.17 12.52 12.01 10.60
Support 2 (S2) 10.67 11.60 10.71 10.40
Support 3 (S3) 9.53 10.67 10.20
Support 4 (S4) 9.59